ASHPOfficial

Despite the passage of the Inflation Reduction Act, drug prices continue to rise. How are manufacturers using the patent, drug approval process, and courts to keep drug prices high, and what are the legislative solutions to these practices?   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast discusses the side effects of GLP-1 agonists and the potential for drug-drug interactions. The episode also includes a discussion on how best to manage these issues when they arise. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacy services can impact various facets of healthcare, including improved patient outcomes, enhanced quality and safety measures, and significant cost avoidance or reduction. Join a panel of key leaders as they share insights on identifying, quantifying, and communicating the value and impact of clinical pharmacy services.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The second in a five-part series, this episode of Tools of The Trade covers different options for data ingestion.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast, hosted by the Pharmacy Administration and Leadership Residents’ Collaborative (PALRC), is intended to inform listeners about opportunities and concerns in the pharmacy leadership pipeline across hospitals and health systems.  Most health-system pharmacy leaders are satisfied with their decision to pursue leadership; however, many also identify opportunities for improvement, including leadership development and growth opportunities, mentorship, and work-life balance.  The development of the pipeline for residents, mid-level managers, and upper-level pharmacy executives is also explored.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode will focus on reviewing the role of an emergency medicine pharmacist, as well as characteristics of an emergency medicine pharmacist that will help them succeed in their practice. CE for this episode expires 2 years after the date it was originally published.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This is first in a two-part feature on emergency medicine presentations from the 2025 ASHP Midyear Clinical Meeting & Exhibition. Members highlight their presentations including the role of bundled care in improving intracranial hemorrhage outcomes, clinical case scenarios to determine the appropriate medication, dosing strategy, and timing for magnesium, ketamine, and TXA based on patient presentation and available evidence, and the role of the pharmacists in cardiac arrest care.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast ASHP Vice President of Member Relations Hannah Vanderpool interviews Daniel Cobaugh on his unique career path in pharmacy, challenges he confronted and overcame as a gay man, and his role as an advocate for LGBTQ people in pharmacy. 

In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Immediate-Past Chair of the Section of Specialty Pharmacy Practitioners Erica Diamantides sits down with the Section of Specialty Pharmacy Practitioners Distinguished Service Awardee Kristel Geyer to discuss what membership within the section and with ASHP means to them and how it has helped develop them into a pharmacy practice leader.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Lindsey Kelley and Daniel Cobaugh will discuss Lindsey’s journey as a pharmacy leader who also happens to be a lesbian woman.  They will hit upon Lindsey’s career experiences, insights from her letter in Letters from Women in Pharmacy, and her guidance for other LGBTQ pharmacy technicians, student pharmacists, pharmacy residents, and pharmacists.  

In celebration of Pride 2026, ASHP is sharing these conversations, from our archives, with members about their lives and career journeys.

The information presented during the podcast reflects solely the opinions of the presenter.  The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.